-
Published21/10/2025
-
Deadline29/10/2025
-
Opening of tenders29/10/2025
-
Today14/11/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Successive supplies of the medicinal product Asciminib to the Maria Skłodowska-Curie National Oncology Institute - National Research Institute of the Gliwice Branch. Text automatically translated in your browsing language Automatically translated
Note: Not all information for this procedure were successfully computed. Please consult linked documents for more details.
1. The subject of this contract is the successive supply of the medicinal product Asciminib to the Maria Skłodowska-Curie National Institute of Oncology - National Research Institute of the Gliwice Branch, hereinafter referred to as the Contracting Authority. 2. The description of the subject of the contract and the conditions for the performance of the contract are contained in the annexes: 1) Product and price specifications – Annex 2.1 to the FTZ, 2) Draft provisions of the contract to be inserted in the content of the contract – Annex 4 to the FTZ. 3. The contracting authority does not divide the contract into lots and thus does not allow the submission of partial tenders. Justification: the subject of the contract is one drug, so there is no possibility of division into parts. 4. The contracting authority did not conduct a preliminary market consultation. 5.The Ordering Party does not provide for supplementary contracts. 6. Information on the contractors’ joint procurement is included in Chapter IX of the FTZ. 7. The deadline for binding the offer is: 120 days. The time limit for binding a tender shall begin to run on the expiry of the time limit for the submission of tenders. This day is the first day of the deadline for binding the offer. The above means that the deadline for binding the offer expires on 25.02.2026. 7. The information clause resulting from Article 13 of Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC, was included by the Contracting Authority in the FTZ. 8.Details of the present proceedings are contained in the FTZ. Text automatically translated in your browsing language Automatically translated
https://ezamowienia.gov.pl/mp-client/tenders/ocds-148610-e40da8dc-0d1e-4a55-afd8-501f0ae9f5d3
https://ezamowienia.gov.pl/mp-client/tenders/ocds-148610-e40da8dc-0d1e-4a55-afd8-501f0ae9f5d3
33600000 - Pharmaceutical products
33690000 - Various medicinal products CVP code deduced from the text of the procedure AI-generated
Type: price
Description: Cena
Weight (percentage, exact):
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.